Literature DB >> 31523650

Prevalence of Dyslipidemia in Urban and Rural Areas of the Northwest of Iran: The Sociodemographic, Dietary and Psychological Determinants.

Jafar Sadegh Tabrizi1, Leila Nikniaz2, Homayoun Sadeghi-Bazargani3, Mostafa Farahbakhsh4, Zeinab Nikniaz5, Mahdieh Abbasalizad Farhangi6, Elham Eghbali5.   

Abstract

BACKGROUND: As dyslipidemia is a preventable risk factor for Coronary heart disease (CHD), precise estimation of its prevalence and determinants is crucial for proper development of health actions. This population-based study aimed at investigating the socioeconomic, dietary and psychological determinants of dyslipidemia in Iran.
METHODS: The data (n=700) for this study were collected in 2015 as a part of the major Lifestyle Promotion Project (LPP) conducted in East Azerbaijan (urban and regional parts). The data for socio-demographic status, dietary information, and physical activity and anxiety levels were collected through validated questionnaires. Then, physical examinations including blood pressure, body mass index (BMI) and conicity index were performed. The levels of serum lipids were measured by enzymatic colorimetric methods.
RESULTS: The prevalence of hypercholesterolemia, high LDL-C, hypertriglyceridemia, low HDL-C and dyslipidemia was 29.4%, 10.3%, 62.3%, 41.4%, 83.3% respectively. The mean TC (184.3±41.2 vs. 174.5±38.1 mg/dl), LDL-C (94.6±30.3 vs. 88.1±28.7 mg/dl) and HDL-C (46.7±10.4 vs. 39.5±8.0 mg/dl) in women were significantly higher than men (P<0.05). However, the mean of TG (182.3±119.3 vs. 145.1±87.8 mg/dl) was significantly higher in men compared to women (P<0.05). Obesity, family history of dyslipidemia, sedentary lifestyle, smoking habits, salt intake, and anxiety were risk factors for different components of dyslipidemia in men and women.
CONCLUSION: Dyslipidemia is a major health problem in northwest of Iran. Focusing on screening, regular drug intake, proper nutrition, physical activity, and changing lifestyles of patients with dyslipidemia are essential.

Entities:  

Keywords:  Anxiety; Dietary intake; Dyslipidemia; Iran; Smoking

Year:  2019        PMID: 31523650      PMCID: PMC6717412     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Cardiovascular disease (CVD) considered as one of the main health problems in Iran (1). A major modifiable factor for the development of CVD is dyslipidemia (2). The prevalence of dyslipidemia is increasing increases constantly as a result of adverse lifestyle changes (3). In an earlier study in Iran, the prevalence of hypercholesterolemia and hypertriglyceridemia estimated to be 27.1% and 19.4% respectively among Iranian adults (4). In Iran, different risk factors including changing in social and economic status of population, huge lifestyle changes, such as Westernization of diet, reduced physical activity and long-term sedentary work, all of considered as main contributors of increase in prevalence of dyslipidemia (5). As dyslipidemia is a preventable risk factor for CVD, exact estimation of its prevalence and patterns is crucial for development of appropriate programs for controlling and managing of harmful clinical consequences. This paper presents the first phase of a comprehensive community-based intervention program for prevention and control of NCDs and their risk factors in Iran (LPP study). To the best of our knowledge, no recent study has been conducted to report the prevalence of dyslipidemia on population level in Iran. To address this gap in knowledge, this study intends to generate relevant information that helps to understand the patterns of dyslipidemia in populations where the prevalence of non-communicable diseases (NCDs) risk factors is growing rapidly.

Methods

The Lifestyle Promotion Project (LPP) dataset was used in the present study. LPP was a cross-sectional population based study conducted in East Azerbaijan (urban and regional parts)-Iran. The exact method of sampling is described in detail elsewhere (6). Five participants were enrolled in each 150 selected clusters (750 participants). By excluding incomplete information, the data of 700 men and women (age range: 15–65 yr) were analyzed. The information of socio-demographic characteristics, physical activity status, severity of general anxiety, dietary data, anthropometric measures, and blood pressure were collected (6). The Ethics Committee of Tabriz University of Medical Science (registration number: 1394.383) was approved the study and informed consent was obtained from all participants. About 5 ml blood sample was collected after an overnight fast. The samples were immediately centrifuged and the serum samples were separated. Enzymatic colorimetric method (by commercial kit of Pars Azmone, Tehran, Iran) was used for meaning the serum level of total cholesterol, High-density lipoprotein and triglyceride and LDL-C was calculated by Friedewald equation (7). We used the NCEP cutoffs for borderline hypercholesterolemia (≥200 mg/dl), hypertriglyceridemia (≥150 mg/dl), high levels of LDL-C (≥ 130 mg/dl) and low levels of HDL-C (<40 mg/dl in males, <50 mg/dl in females). All statistical analyses were performed in SPPS (ver. 18, Chicago, IL, USA). Continuous and categorical variables were reported as means and standard deviations (SDs) and proportions respectively. Independent t-test and chi-square were used for between-group comparisons. The multinomial logistic regression models were used to examine the relationships between dyslipidemia components and associated factors by adjusting for covariates including residency area, education, employment, smoking, physical activity, age, anxiety, family history of dyslipidemia and dietary factors. A significance level of 0.05 was used.

Results

Table 1 presents the general characteristics of participants stratified by residency area. About 52.5% of participants were living in urban areas and 47.4% of them were living in regional areas.
Table 1:

General characteristics of participants in urban and regional areas

CharacteristicsUrban (n= 368)regional (n= 332)Total (n= 700)
Age (yr), % (n)*
18–254.3 (16)5.2 (17)4.8 (33)
26–3514.7 (54)15.3 (51)15.0 (105)
36–4526.3 (97)27.0 (90)26.6 (187)
46–5527.2 (100)31.5 (104)29.2 (204)
56–6527.6 (101)21.0 (70)24.4 (171)
Marital status, % (n)
Married*90.7 (334)91.3 (303)91.0 (637)
Occupational status, % (n)
Employed or self employed32.7 (120)35.7 (118)34.2 (238)
Student3.3 (12)2.1 (7)2.7 (19)
Unemployed64.0 (236)62.2 (207)63.2 (443)
Educational status, % (n)*
Illiterate8.9 (33)18.3 (61)13.4 (94)
Under graduate73.2 (269)69.2 (230)71.3 (499)
University17.9 (66)12.5 (41)15.1 (107)
Smoking habit, % (n)*
yes6.4 (23)8.8 (29)7.4 (52)
Occasionally2.1 (8)14.7 (49)8.1 (57)
No91.5 (337)76.5 (254)84.4 (591)
Physical activity, % (n)*
Inactive51.6 (190)21.3 (71)37.3 (261)
Minimally active31.3 (115)28.1 (93)29.7 (208)
Health enhancing activity17.1 (63)50.6 (168)34.3 (231)

(P<0.05), differences tested by chi-square test

General characteristics of participants in urban and regional areas (P<0.05), differences tested by chi-square test Prevalence of borderline and high serum lipids in urban and regional areas is shown in Table 2. The residents of regional areas significantly had lower HDL-C level and higher dyslipidemia compared with urban ones.
Table 2:

Prevalence of borderline and high serum lipids in urban and regional areas

Lipid profileUrban (n= 368)regional (n= 332)Total (n= 700)
Prevalence of borderline high and high TC, % (n)29.9 (110)29.2 (97)29.6 (207)
Prevalence of borderline high and high LDL-C, % (n)10.1 (37)10.6 (35)10.3 (72)
Prevalence of borderline high and high TG, % (n)43.2 (159)40.4(134)41.8 (293)
Prevalence of low HDL-C, % (n)*57.1 (210)67.5 (224)62.0 (434)
Prevalence of dyslipidemia, % (n)*80.5 (296)86.5 (287)83.3 (583)

(P<0.05), differences tested by chi-square test

Prevalence of borderline and high serum lipids in urban and regional areas (P<0.05), differences tested by chi-square test The prevalence of dyslipidemia, hypertriglyceridemia, hypercholesterolemia, hyper LDL-cholesterolemia, and hypo HDL-cholesterolemia was 83.3%, 62.3%, 29.4%, 10.3%, and 41.4% respectively. Moreover, 8.6% of Iranian adults had mixed dyslipidemia (hyper LDL-cholesterolemia with either hypo HDL-cholesterolemia and/or hypertriglyceridemia), with nearly 2.8% had all three lipid abnormalities (it has not been shown). The prevalence of different lipid abnormalities across different age and sex groups is presented in Table 3. The mean total cholesterol (184.3±41.2 vs. 174.5±38.1 mg/dl), LDL-C (94.6±30.3 vs. 88.1±28.7 mg/dl) and HDL-C (46.7±10.4 vs. 39.5±8.0 mg/dl) in women were significantly higher than men. However, the mean of TG (182.3±119.3 vs. 145.1±87.8 mg/dl) was significantly higher in men compared to women. Middle-aged participants had significantly higher prevalence of dyslipidemia in compared with younger participants.
Table 3:

The prevalence of high total cholesterol, high LDL-C, and high TG, low HDL-C and dyslipidemia by age and sex

VariablesMenWomenP value[]
Prevalence of borderline high and high TC, (%)22.334.00.003
15–25 (yr)7.716.70.399
26–3511.521.30.30
36–4519.224.70.46
46–5526.434.40.32
56–6528.356.50.002
P-value 0.23<0.001
Prevalence of borderline high and high LDL-C, (%)8.711.50.287
15–25 (yr)0.08.30.14
26–353.84.30.91
36–455.811.30.28
46–553.89.50.20
56–6519.217.40.79
P-value 0.0170.26
Prevalence of borderline high and high TG, (%)51.634.1<0.001
15–25 (yr)30.88.30.039
26–3526.927.70.94
36–4557.731.30.003
46–5562.330.2<0.001
56–6553.849.30.62
P-value 0.020.14
Prevalence of low HDL-C, (%)55.967.00.009
15–25 (yr)53.866.70.522
26–3569.266.00.77
36–4563.576.50.1
46–5554.763.50.29
56–6547.260.90.13
P-value 0.320.28
Prevalence of dyslipidemia, %80.885.00.2
15–25 (yr)69.290.90.041
26–3576.978.70.86
36–4590.290.10.98
46–5584.981.30.57
56–6573.688.40.03
P-value 0.150.27
Prevalence of dyslipidemia awareness, %3.35.9<0.001
15–25 (yr)0.20.00.37
26–350.00.10.26
36–452.02.80.30
46–556.78.00.33
56–655.918.8<0.001
P-value<0.001<0.001

Differences tested by chi-square test

Differences tested by Kruskal-Wallis

The prevalence of high total cholesterol, high LDL-C, and high TG, low HDL-C and dyslipidemia by age and sex Differences tested by chi-square test Differences tested by Kruskal-Wallis Furthermore, 9.2% of the dyslipidemic patients were aware of their disease, however, only 55.0% of the aware ones were receiving medication or TLC. The association between borderline high and high serum lipids with demographic, socio-economic and lifestyle factors were presented in Tables 4 and 5.
Table 4:

Logistic regression analysis for the association of borderline high and high serum lipids and demographic, socio-economic, and lifestyle factors in men

VariablesBorderline high and high LDL-C Adjusted OR (95% CI)Borderline high and high TC Adjusted OR (95% CI)Borderline high and high TG Adjusted OR (95% CI)Low HDL-C Adjusted OR (95% CI)
Age groups(yr0
15–251.001.001.001.00
26–358.70 (0.02,17.6)1.39 (0.08, 3.37)1.01 (0.18, 2.15)2.53 (0.72, 5.39)
36–452.96 (0.40, 5.74)1.93 (0.18, 2.71)1.08 (0.09,1.74)1.46(0.16, 3.13)
46–551.91 (0.32,3.16)2.14 (0.91, 7.76)1.09 (1.00, 3.19)1.82 (0.38, 4.32)
56–651.00 (0.13, 1.85)2.05 (0.59, 3.30)1.19 (0.44, 2.09)1.78 (0.18, 3.77)
Residential place
Urban1.001.001.001.00
Rural0.28 (0.06, 1.94)0.16 (0.01, 2.5)0.33 (0.03, 3.10)4.76 (1.46, 15.83)*
Marital status
Single1.001.001.001.00
Married0.87 (0.05, 2.85)5.51 (0.06, 2.93)0.29 (0.01, 7.60) *2.18 (0.18, 3.63)
Occupational status
Employed1.001.001.001.00
Student0.81 (0.06, 1.72)1.15 (0.29, 4.63)1.08 (0.33, 2.94)1.14 (0.46, 2.15)
Unemployed0.79 (0.07, 8.25)1.06 (0.02, 1.19)7.80 (0.47, 25.65)2.21 (0.17, 5.73)
Educational status
Illiterate1.001.001.001.00
Under graduate1.55 (0.31, 7.73)0.01 (0.00, 3.66)0.23 (0.03, 1.55)1.47 (0.04, 4.91)
College1.33 (0.11, 15.13)0.06 (0. 01, 1.95)0.10 (0.01, 3.62)1.27 (0.03,4.42)
Smoking habit
yes1.001.001.001.00
Occasionally2.93 (0.11, 10.14)0.34 (0.17, 1.09)1.17 (0.34,1.99)0.12 (0.01, 1.19)
No0.72 (0.05, 2.56)0.22 (0.09, 0.75) *0.15 (0.07, 1.57)0.24 (0.03, 0.84) *
Physical activity
Inactive1.001.001.001.00
Minimally active0.78 (0.17, 3.81)0.48 (0.03, 2.67)0.34 (0.04, 2.44)0.44 (0.11, 1.49)
Health enhancing activity0.42 (0.09, 2.37)0.54 (0.38, 1.71)0.40 (0.12, 1.38)0.62 (0.18, 1.76)
Family history of dyslipidemia
No1.001.001.001.00
Yes1.56 (0.32, 7.56)13.33 (5.33, 22.81) **1.37 (0.07, 3.68)1.16 (0.12, 3.82)
Overweight and obesity
No1.001.00
Yes2.99 (1.72, 8.98) **24.56 (1.81, 33.34) *14.66 (2.03, 105.10) ***5.95 (1.11, 31.50) *
High conicity index
No1.001.001.00
Yes1.49 (0.11, 5.61)3.29 (0.78, 4.71)1.58 (1.15, 4.16) *1.86 (0.11, 2.95)
Generalized Anxiety Disorder
No anxiety1.001.001.001.00
Mild1.57 (0.17, 1.88)1.58 (0.51, 6.60)1.32 (0.44, 3.96)0.75 (0.12, 1.09)
Moderate1.87 (0.14, 2.01)1.87 (0.70, 2.95)2.67 (0.97, 4.82)1.16 (0.44, 1.88)
Severe1.65 (0.04, 1.91)2.05 (0.93, 6.73)5.94 (1.70, 42.29) *2.37 (0.30, 6.61)
Having hypertension
No1.001.001.00
Yes1.15 (0.31, 4.39)1.54 (0.04, 6.40)1.51 (0.65, 3.71)1.82 (0.38, 4.29)
Having diabetes
No1.001.001.00
Yes1.76 (0.83, 6.74)1.09 (0.11, 3.22)2.30 (0.86, 7.14)4.20 (0.93, 8.69)
Salt intake (gr/day)
Tertile 11.001.001.001.00
Tertile 21.24 (0.71, 3.51)51.32 (2.71, 969.8) ***1.62 (0.75, 2.96)1.37 (0.71, 3.08)
Tertile 31.12 (0.30, 3.29)57.69 (1.40, 238.2) **1.29 (0.43, 3.00)1.18 (0.26, 2.19)
Refined carbohydrate intake (gr/day)
Tertile 11.001.001.001.00
Tertile 21.08 (0.03, 2.85)1.55 (0.83, 3.49)1.14 (1.02, 5.19) *0.9 (0.09, 2.33)
Tertile 31.09 (0.10, 1.96)1.47 (0.32, 3.36)1.21 (1.06, 5.63) *1.03 (0.01, 1.26)
Saturated fat intake (gr/day)
Tertile 11.001.001.001.00
Tertile 21.11 (0. 23, 2.36)1.46 (0.47, 4.52)1.97 (0.15, 3.86)1.75 (0.70, 3.33)
Tertile 31.19 (0.73, 2.97)1.93 (0.84, 5.34)1.15 (0.20, 3.19)1.88 (0.73, 3.20)

P<0.05,

P<0.01,

P<0.001, Multiple logistic regressions considering the simultaneous effect of all the explanatory variables

Table 5:

Logistic regression analysis for the association of borderline high and high serum lipids and demographic, socio-economic, and lifestyle factors in women

VariablesBorderline high and high LDL-C Adjusted OR (95% CI)Borderline high and high TC Adjusted OR (95% CI)Borderline high and high TG Adjusted OR (95% CI)Low HDL-C Adjusted OR (95% CI)
Age groups(yr)
15–251.001.001.001.00
26–351.55 (0.03,8.19)1.34 (0.90, 3.12)1.28 (0.06, 2.44)1.70 (0.19, 4.29)
36–451.20 (0.14, 3.18)1.70 (0.97, 5.55)3.57 (0.22,6.51)1.51 (0.19, 3.82)
46–551.30 (0.16,6.38)1.30 (0.18, 3.36)3.03 (0.18, 5.14)1.24 (0.84, 3.79)
56–651.57 (0. 42, 2.22)2.04 (0.24, 3.30)4.93 (0.28,9.38)1.40 (0.46, 3.51)
Residential place
Urban1.001.001.001.00
Rural0.78 (0.0.23, 2.42)1.20 (0.51, 2.71)1.70 (0.69, 2.09)1.74 (1.08, 4.84) [*]
Marital status
Single1.001.001.001.00
Married2.25 (0.16 3.14)0.41 (0.06, 2.20)0.43 (0.06, 3.22)1.41 (0.24, 4.08)
Occupational status
Employed1.001.001.001.00
Student0.41 (0.01, 2.63)0.59 (0.22, 1.29)0.31 (0.10, 1.51)1.17 (0.28, 4.18)
Unemployed2.56 (0.04, 3.86)1.39 (0.30, 3.44)0.44 (0.05, 2.77)1.63 (0.10, 3.67)
Educational status
Illiterate1.001.001.001.00
Under graduate0.17 (0.04, 1.11)0.50 (0.19, 1.97)0.78 (0.17, 2.76)0.56 (0.45, 1.68)
College0.63 (0.04, 4.23)0.95 (0.18, 2.00)0.76 (0.10, 1.93)0.29 (0.05,1.99)
Smoking habit
yes1.001.001.001.00
Occasionally2.72 (0.62, 3.27)1.07 (0.09, 3.13)0.69 (0.02,3.34)0.16 (0.08, 1.62)
No0.46 (0.07, 1.81)0.77 (0.19, 1.44)0.81 (0.30 1.59)0.56 (0.12, 1.67)
Physical activity
Inactive1.001.001.001.00
Minimally active0.38 (0.29, 6.13)0.42 (0.15, 0.73)[*]0.27 (0.09, 0.82) [*]0.32 (0.17, 0.84) [*]
Health enhancing activity0.91 (0.45, 2.64)0.50 (0.20, 0.81)[*]0.49 (0.17, 0.92) [*]0.38 (0.16, 0.73) [*]
Family history of dyslipidemia
No1.001.001.001.00
Yes2.97 (0.54, 16.08)2.25 (0.67, 7.73)1.78 (1.30, 2.43) [***]1.56 (0.17, 3.14)
Overweight and obesity
No1.001.00
Yes5.07 (1.17, 9.44) [*]1.93 (1.07, 3.19) [*]10.34 (2.85, 37.24) [***]2.14 (1.06, 6.98) [*]
Conicity index
No1.001.001.00
Yes1.81 (0.27, 11.10)2.6 (0.80, 8.20)3.04 (1.27, 12.58) [*]1.01 (0.34, 2.31)
Generalized Anxiety Disorder
No anxiety1.001.001.001.00
Mild1.83 (0.14, 4.49)1.34 (0.60, 3.58)0.79 (0.31, 1.91)1.35 (0.36, 5.51)
Moderate1.57 (0.17, 1.73)1.58 (0.16, 2.29)1.10 (0.26, 3.13)1.35 (0.58, 4.96)
Severe1.72 (0.46, 3.93)1.61 (0.12, 3.38)1.27 (1.07, 3.26) [*]2.19 (0.31, 6.73)[*]
Having Hypertension
No1.001.001.00
Yes1.07 (0.33, 3.66)0.94 (0.42, 2.27)1.22 (0.82, 1.93)1.43 (0.6, 3.85)
Having Diabetes
No1.001.001.00
Yes1.34 (0.25, 7.29)1.05 (0.26, 4.31)5.57 (1.14, 27.26) [*]1.65 (0.16, 2.63)
Salt intake (gr/day)
Tertile 11.001.001.00
Tertile 22.67 (0.66, 10.08)2.95 (1.14, 7.62) [*]1.86 (0.33, 2.14)1.00 (0.37, 2.20)
Tertile 32.16 (0.51, 9.27)2.80 (1.16, 6.71) [*]4.16 (1.44, 11.09) [**]1.37 (0.15, 3.29)
Refined carbohydrate intake (gr/day)
Tertile 11.001.001.001.00
Tertile 21.16 (0.31, 3.58)1.37 (0.04, 4.34)1.97 (1.22, 5.73) [*]1.60 (0.55, 3.81)
Tertile 31.15 (0.27, 2.59)1.74 (0.02, 3.12)1.48 (1.13, 4.16) [*]1.28 (0.69, 3.00)
Saturated fat intake (gr/day)
Tertile 11.001.001.001.00
Tertile 21.08 (0.09, 1.48)1.39 (0.01, 4.12)1.54 (0.07, 2.19)1.74 (0.39, 4.93)
Tertile 31.21 (0.39, 2.16)1.63 (0.02, 5.38)1.23 (0.01, 2.55)1.18 (0.06, 3.29)

P<0.05,

P<0.01,

P<0.001, Multiple logistic regressions considering the simultaneous effect of all the explanatory variable

Logistic regression analysis for the association of borderline high and high serum lipids and demographic, socio-economic, and lifestyle factors in men P<0.05, P<0.01, P<0.001, Multiple logistic regressions considering the simultaneous effect of all the explanatory variables Logistic regression analysis for the association of borderline high and high serum lipids and demographic, socio-economic, and lifestyle factors in women P<0.05, P<0.01, P<0.001, Multiple logistic regressions considering the simultaneous effect of all the explanatory variable According to the results of adjusted logistic regression, the risk of dyslipidemia was higher in overweight and obese men and women. Family history of hyperlipidemia and higher levels of salt intake were associated with high TC levels in men. Moreover, abdominal obesity, anxiety and higher refined carbohydrate intake were associated with high TG levels. Regional residents were more likely to have low HDL-C. Additionally, the risk of high TC and low HDL-C was lower in non-smoker subjects. In women, being active was a protective factor for high TC, high TG and low HDL-C levels. Higher intake of salt was related to greater risk of high TC levels. In addition, there was an association between high TG levels and abdominal obesity, having diabetes and higher refined carbohydrate intake. Additionally, regional residents were more likely to had low levels of HDL-C. In males and females, age, marriage, employment, education status, and hypertension were not associated with dyslipidemia.

Discussion

In the present study the prevalence of dyslipidemia and its associated factors in the urban and rural region of East Azerbaijan. The prevalence of hypercholesterolemia (29.6%) in this study was higher than the reported value in Nepal (17.2%) (8) and India (23.2%) (9) and lower than the values estimated prevalence in U.S (40.5%) (10) and Portugal (56.7%) (11). The prevalence of hyper LDL-cholesterolemia (10.3%) and hypo HDL-cholesterolemia (62%) was respectively lower and higher than the reports from the US (11), Switzerland (12) and Turkey ((13). Hypertriglyceridemia prevalence (41.8%) was lower than the reports from Nepal (8); however, it was higher than the most other western or eastern countries such as US (27%) (11), Italy (19.2%) (14), Portugal (26%) (10) and India (37.7%) (9). This discrepancy between the results from different countries may be due to differences in genetic aspects, obesity prevalence and dissimilarities in lifestyle. According to the results of present study, the main forms of dyslipidemia were hypo HDL-cholesterolemia and hypertriglyceridemia. These findings were in line with the reports of other Asian countries (15, 16). These observations may be due to the higher intake of simple carbohydrates fat that could affect the level of serum triglyceride (17). In conformity with other studies (18), the prevalence of dyslipidemia was higher in women compared with men. This finding may be related to the higher prevalence of obesity and abdominal obesity in women. Additionally, in this study, the prevalence of obesity (32.2% versus 15.1%) and abdominal obesity (81.4% versus 68.6%) was significantly higher in women compared to men. Furthermore, in male subjects, a significant increase was observed in the prevalence of LDL-cholesterolemia and hypertriglyceridemia with increasing age. In women, increasing age was related to the prevalence of high TC. In multiple regression analysis, no significant association was found between age and any of the lipid components. This finding may be related to the high prevalence of dyslipidemia in both young and middle-aged adults in this population. Similar to previous studies (19, 20, 21), obesity was identified as risk factors for all types of dyslipidemia in our study both in men and women. Hence, as a first-stage screening tool, high BMI may be considered to detect dyslipidemic individuals among Iranian adults. Moreover, family history of dyslipidemia, sedentary lifestyle, smoking habits, salt intake and anxiety were other risk factors for different components of dyslipidemia in men and women. In addition, in this study, for the first time, high levels of salt intake had positive association with hypercholesterolemia. Adding salt to food can lead to passive overconsumption of fat and calorie in adults. Besides, fat and salt are common and appetitive combinations in food. Therefore, higher salt intake increases the possibility of being overweight and consecutively higher prevalence of elevated TC and dyslipidemia (22). In accordance with previous study (23), we showed that anxiety was related to higher prevalence of elevated TG. The hypothesis is that activated hypothalamic-pituitary-adrenocortical (HPA) axis in response to stress resulted in increased atherogenic lipid profile. In this study, being a regional residence increased the prevalence of low HDL level. Rural subjects in Iran tended to have higher animal fat intake which is highly possible cause of higher prevalence of low HDL-C and dyslipidemia in rural areas. Similar to previous reports, in this study, being active was a protective factor for high TC, high TG and low HDL-C levels in women. Physical activity could effects on blood cholesterol and other lipids by increasing their metabolism. However, its effect of LDL-cholesterol is low and also it has been suggested the cholesterol-lowering effect of dietary interventions is higher than exercise (14). Therefore, it is suggested to merge diet with exercise.(24) The results of current study showed that approximately 9.2% of the patients with dyslipidemia were aware of their disease and only half of them were receiving lipid-lowering medication or TLC. The awareness in this study was approximately similar to the reported data from China (9.9%) and it was significantly lower than reports from USA (63%). Women were significantly more aware than men. The exact reasons for the observed differences between males and females are unidentified; however, women express their health problem more than men and also seeking healthcare services more than men (25).

Conclusion

Dyslipidemia, mainly hypertriglyceridemia and low HDL-C, is very common in Azerbaijan, Iran and knowledge and control of dyslipidemia in this population was low. Therefore, implementing proper educational programs to increase health literacy regarding the importance of regular drug consumption, physical activity, anxiety management, proper nutrition, are essential especially among old population. Moreover, programs to improve the surveillance systems and appropriate intervention programs are desired.

Ethical considerations

Ethical issues (Including plagiarism, informed consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.
  22 in total

Review 1.  Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries: a review of population-based studies carried out from 1979 to 2002.

Authors:  Ricardo Fuentes; Tuulikki Uusitalo; Pekka Puska; Jaakko Tuomilehto; Aulikki Nissinen
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2003-12

2.  Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.

Authors:  Ninh T Nguyen; Cheryl P Magno; Karen T Lane; Marcelo W Hinojosa; John S Lane
Journal:  J Am Coll Surg       Date:  2008-10-10       Impact factor: 6.113

Review 3.  Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review. Part I.

Authors:  João Costa; Margarida Borges; Eduardo Oliveira; Miguel Gouveia; António Vaz Carneiro
Journal:  Rev Port Cardiol       Date:  2003-04       Impact factor: 1.374

4.  Lipid profiles and prevalence of dyslipidemia in schoolchildren in south Khorasan Province, eastern Iran.

Authors:  Azita Fesharakinia; Asghar Zarban; Gholam-Reza Sharifzadeh
Journal:  Arch Iran Med       Date:  2008-11       Impact factor: 1.354

5.  Dyslipidemia and high waist-hip ratio in women with self-reported social anxiety.

Authors:  Mikael Landén; Fariba Baghaei; Roland Rosmond; Göran Holm; Per Björntorp; Elias Eriksson
Journal:  Psychoneuroendocrinology       Date:  2004-09       Impact factor: 4.905

6.  Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.

Authors:  Cihangir Erem; Arif Hacihasanoglu; Orhan Deger; Mustafa Kocak; Murat Topbas
Journal:  Endocrine       Date:  2008-11-12       Impact factor: 3.633

7.  Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal.

Authors:  Sanjib Kumar Sharma; Anup Ghimire; Jeyasundar Radhakrishnan; Lekhjung Thapa; Nikesh Raj Shrestha; Navaraj Paudel; Keshar Gurung; Maskey R; Anjali Budathoki; Nirmal Baral; David Brodie
Journal:  Int J Hypertens       Date:  2011-04-19       Impact factor: 2.420

8.  The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population--mainly a function of overweight?

Authors:  Gunilla Hollman; Margareta Kristenson
Journal:  Eur J Cardiovasc Nurs       Date:  2007-06-22       Impact factor: 3.908

9.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.

Authors:  Benjamin F Voight; Gina M Peloso; Marju Orho-Melander; Ruth Frikke-Schmidt; Maja Barbalic; Majken K Jensen; George Hindy; Hilma Hólm; Eric L Ding; Toby Johnson; Heribert Schunkert; Nilesh J Samani; Robert Clarke; Jemma C Hopewell; John F Thompson; Mingyao Li; Gudmar Thorleifsson; Christopher Newton-Cheh; Kiran Musunuru; James P Pirruccello; Danish Saleheen; Li Chen; Alexandre F R Stewart; Arne Schillert; Unnur Thorsteinsdottir; Gudmundur Thorgeirsson; Sonia Anand; James C Engert; Thomas Morgan; John Spertus; Monika Stoll; Klaus Berger; Nicola Martinelli; Domenico Girelli; Pascal P McKeown; Christopher C Patterson; Stephen E Epstein; Joseph Devaney; Mary-Susan Burnett; Vincent Mooser; Samuli Ripatti; Ida Surakka; Markku S Nieminen; Juha Sinisalo; Marja-Liisa Lokki; Markus Perola; Aki Havulinna; Ulf de Faire; Bruna Gigante; Erik Ingelsson; Tanja Zeller; Philipp Wild; Paul I W de Bakker; Olaf H Klungel; Anke-Hilse Maitland-van der Zee; Bas J M Peters; Anthonius de Boer; Diederick E Grobbee; Pieter W Kamphuisen; Vera H M Deneer; Clara C Elbers; N Charlotte Onland-Moret; Marten H Hofker; Cisca Wijmenga; W M Monique Verschuren; Jolanda M A Boer; Yvonne T van der Schouw; Asif Rasheed; Philippe Frossard; Serkalem Demissie; Cristen Willer; Ron Do; Jose M Ordovas; Gonçalo R Abecasis; Michael Boehnke; Karen L Mohlke; Mark J Daly; Candace Guiducci; Noël P Burtt; Aarti Surti; Elena Gonzalez; Shaun Purcell; Stacey Gabriel; Jaume Marrugat; John Peden; Jeanette Erdmann; Patrick Diemert; Christina Willenborg; Inke R König; Marcus Fischer; Christian Hengstenberg; Andreas Ziegler; Ian Buysschaert; Diether Lambrechts; Frans Van de Werf; Keith A Fox; Nour Eddine El Mokhtari; Diana Rubin; Jürgen Schrezenmeir; Stefan Schreiber; Arne Schäfer; John Danesh; Stefan Blankenberg; Robert Roberts; Ruth McPherson; Hugh Watkins; Alistair S Hall; Kim Overvad; Eric Rimm; Eric Boerwinkle; Anne Tybjaerg-Hansen; L Adrienne Cupples; Muredach P Reilly; Olle Melander; Pier M Mannucci; Diego Ardissino; David Siscovick; Roberto Elosua; Kari Stefansson; Christopher J O'Donnell; Veikko Salomaa; Daniel J Rader; Leena Peltonen; Stephen M Schwartz; David Altshuler; Sekar Kathiresan
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321

10.  The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome.

Authors:  Mathieu Firmann; Vladimir Mayor; Pedro Marques Vidal; Murielle Bochud; Alain Pécoud; Daniel Hayoz; Fred Paccaud; Martin Preisig; Kijoung S Song; Xin Yuan; Theodore M Danoff; Heide A Stirnadel; Dawn Waterworth; Vincent Mooser; Gérard Waeber; Peter Vollenweider
Journal:  BMC Cardiovasc Disord       Date:  2008-03-17       Impact factor: 2.298

View more
  1 in total

1.  Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey.

Authors:  Marzieh Nikparvar; Mohadeseh Khaladeh; Hadi Yousefi; Mohammadsadegh Vahidi Farashah; Behzad Moayedi; Masoumeh Kheirandish
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.